house · trading 2020-02-12 → 2020-03-07
*Notional-weighted price return on disclosed buys, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2020-03-07 | GSK | BUY | $1K–$15K | $42.38 | $52.50 2026-06-26 | +23.9% |
| 2020-03-04 | AMD | BUY | $1K–$15K | $50.11 | $521.58 2026-06-26 | +940.9% |
| 2020-02-26 | GSK | BUY | $1K–$15K | $41.90 | $52.50 2026-06-26 | +25.3% |
| 2020-02-12 | GSK | BUY | $1K–$15K | $44.23 | $52.50 2026-06-26 | +18.7% |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Hon. Mike Kelly | 2 · AMD, GSK |
| Hon. Roger W. Marshall | 2 · AMD, GSK |
| Hon. Marjorie Taylor Mrs Greene | 2 · AMD, GSK |
| Thomas H Tuberville | 2 · AMD, GSK |
| Hon. David Kustoff | 2 · AMD, GSK |
| John Boozman | 2 · AMD, GSK |
| Hon. Virginia Foxx | 1 · GSK |
| Hon. Kenny Marchant | 1 · GSK |
| Hon. Kurt Schrader | 1 · GSK |
| Hon. Fred Upton | 1 · GSK |
| Hon. James B. Renacci | 1 · GSK |
| Hon. Josh Gottheimer | 1 · AMD |